DK137762B - Praktisk taget rene 7alfa-methyl-estr-4-en-forbindelser til anvendelse som antifertilitetsmidler samt fremgangsmåde til fremstilling af de omhandlede forbindelse. - Google Patents
Praktisk taget rene 7alfa-methyl-estr-4-en-forbindelser til anvendelse som antifertilitetsmidler samt fremgangsmåde til fremstilling af de omhandlede forbindelse.Info
- Publication number
- DK137762B DK137762B DK568674AA DK568674A DK137762B DK 137762 B DK137762 B DK 137762B DK 568674A A DK568674A A DK 568674AA DK 568674 A DK568674 A DK 568674A DK 137762 B DK137762 B DK 137762B
- Authority
- DK
- Denmark
- Prior art keywords
- 7alpha
- estr
- methyl
- preparation
- subject compound
- Prior art date
Links
- FJRDNNPLOYCCHE-UCWSCHQOSA-N (7R,8R,9S,10R,13S,14S)-7,13-dimethyl-1,2,3,6,7,8,9,10,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthrene Chemical class C[C@H]1[C@H]2[C@@H]3CCC[C@@]3(C)CC[C@@H]2[C@H]2CCCC=C2C1 FJRDNNPLOYCCHE-UCWSCHQOSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 239000003433 contraceptive agent Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
- C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
- C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
- C07J1/0074—Esters
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US411791A US3928398A (en) | 1973-11-01 | 1973-11-01 | Derivatives of 7{60 -methylestr-4-en-3{60 ,17{62 -diol |
Publications (3)
Publication Number | Publication Date |
---|---|
DK568674A DK568674A (da) | 1975-06-23 |
DK137762B true DK137762B (da) | 1978-05-01 |
DK137762C DK137762C (da) | 1978-11-06 |
Family
ID=23630345
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK568674AA DK137762B (da) | 1973-11-01 | 1974-10-31 | Praktisk taget rene 7alfa-methyl-estr-4-en-forbindelser til anvendelse som antifertilitetsmidler samt fremgangsmåde til fremstilling af de omhandlede forbindelse. |
Country Status (11)
Country | Link |
---|---|
US (1) | US3928398A (da) |
JP (1) | JPS5071666A (da) |
CA (1) | CA1020544A (da) |
CH (1) | CH614721A5 (da) |
DE (1) | DE2450036A1 (da) |
DK (1) | DK137762B (da) |
FR (1) | FR2249675B1 (da) |
GB (1) | GB1438889A (da) |
IL (1) | IL45807A (da) |
NL (1) | NL7413751A (da) |
SE (1) | SE416053B (da) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4073899A (en) * | 1974-09-16 | 1978-02-14 | Richardson-Merrell, Inc. | Method of terminating pregnancy |
JPS589574B2 (ja) * | 1978-12-18 | 1983-02-22 | ティーディーケイ株式会社 | 自動巻線機のからげ装置 |
MX9301121A (es) | 1992-03-02 | 1993-09-01 | Schering Ag | Metodo y equipo para la contracepcion oral y regulacion de la menstruacion con estrogeno/progestina/aniprogestina. |
US7704983B1 (en) | 1992-03-02 | 2010-04-27 | Eastern Virginia Medical School | Antiprogestin method for reducing side effects associated with low dosage HRT and oral contraception |
US5439913A (en) | 1992-05-12 | 1995-08-08 | Schering Aktiengesellschaft | Contraception method using competitive progesterone antagonists and novel compounds useful therein |
US5516769A (en) * | 1993-02-19 | 1996-05-14 | The Medical College Of Hampton Roads | Method of inhibiting fertilization |
US5468736A (en) * | 1993-02-25 | 1995-11-21 | The Medical College Of Hampton Road | Hormone replacement therapy |
DE4344463A1 (de) * | 1993-12-22 | 1995-06-29 | Schering Ag | Kombinationsprodukt zur Kontrazeption |
PL356465A1 (en) * | 2002-10-04 | 2004-04-05 | ANPHARM Przedsiębiorstwo Farmaceutyczne S.A. | METHOD OF MANUFACTURE OF 17beta-HYDROXY-7alpha-METHYL-19-NOR-17alpha-PREGN-5(10)-ENE-20-YNE-3-ONE |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3262949A (en) * | 1956-11-13 | 1966-07-26 | Syntex Corp | 7-methyl androstane compounds |
BE640298A (da) * | 1962-11-23 | |||
BE642575A (da) * | 1963-01-16 | |||
US3846456A (en) * | 1965-04-07 | 1974-11-05 | Upjohn Co | Organic compounds |
US3384543A (en) * | 1965-04-07 | 1968-05-21 | Upjohn Co | 7alpha-methyl-5-androstanes |
US3423404A (en) * | 1965-10-21 | 1969-01-21 | Searle & Co | (optionally 17-alkylated) estra-4,9(10)-diene - 3alpha/3beta,17beta - diols and esters corresponding |
-
1973
- 1973-11-01 US US411791A patent/US3928398A/en not_active Expired - Lifetime
-
1974
- 1974-09-23 CA CA209,767A patent/CA1020544A/en not_active Expired
- 1974-10-07 IL IL45807A patent/IL45807A/en unknown
- 1974-10-21 NL NL7413751A patent/NL7413751A/xx not_active Application Discontinuation
- 1974-10-22 DE DE19742450036 patent/DE2450036A1/de not_active Withdrawn
- 1974-10-28 CH CH1441074A patent/CH614721A5/xx not_active IP Right Cessation
- 1974-10-29 JP JP49123987A patent/JPS5071666A/ja active Pending
- 1974-10-30 SE SE7413684A patent/SE416053B/xx unknown
- 1974-10-31 DK DK568674AA patent/DK137762B/da unknown
- 1974-10-31 FR FR7436464A patent/FR2249675B1/fr not_active Expired
- 1974-10-31 GB GB4726674A patent/GB1438889A/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
IL45807A0 (en) | 1974-12-31 |
DE2450036A1 (de) | 1975-05-07 |
AU7369074A (en) | 1976-04-01 |
FR2249675A1 (da) | 1975-05-30 |
FR2249675B1 (da) | 1977-11-04 |
US3928398A (en) | 1975-12-23 |
DK568674A (da) | 1975-06-23 |
GB1438889A (en) | 1976-06-09 |
CH614721A5 (da) | 1979-12-14 |
DK137762C (da) | 1978-11-06 |
IL45807A (en) | 1977-10-31 |
SE7413684L (da) | 1975-05-02 |
CA1020544A (en) | 1977-11-08 |
SE416053B (sv) | 1980-11-24 |
JPS5071666A (da) | 1975-06-13 |
NL7413751A (nl) | 1975-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK134345B (da) | Analogifremgangsmåde til fremstilling af 4-hydroxymethyl-1-phthalazonderivater. | |
DK155043C (da) | Analogifremgangsmaade til fremstilling af polyenforbindelser | |
DK135376B (da) | Fremgangsmåde til fremstilling af piperazinylquinazolin-forbindelser. | |
DK138791B (da) | Analogifremgangsmåde til fremstilling af 2,6-disubstituerede fenylaminoguanidinforbindelser. | |
DK137277B (da) | Analogifremgangsmåde til fremstilling af ferrocenforbindelser. | |
DK140484B (da) | Fremgangsmåde til fremstilling af zeaxanthin. | |
DK137762B (da) | Praktisk taget rene 7alfa-methyl-estr-4-en-forbindelser til anvendelse som antifertilitetsmidler samt fremgangsmåde til fremstilling af de omhandlede forbindelse. | |
DK137679B (da) | Analogifremgangsmåde til fremstilling af thienotriazoldiazepinderivater eller syreadditionssalte deraf. | |
DK138641B (da) | Analogifremgangsmåde til fremstilling af tricycliske forbindelser eller syreadditionssalte deraf. | |
DK134279B (da) | Analogifremgangsmåde til fremstilling af cycloalkylphenoxycarboxylsyrederivater. | |
DK136827B (da) | 17beta-hyroxy-3-oxo-4,6-steroiddien-17alfa-methylmalonsyrederivater til brug som mellemprodukter til fremstilling af 17-spirolactoner samt fremgangsmåde til fremstilling af mellemprodukterne. | |
DK137577B (da) | Fremgangsmåde til fremstilling af zeaxanthin. | |
DK134915B (da) | Analogifremgangsmåde til fremstilling af N-halogenalkyl-N-nitrosocarbamater eller N4-halogenalkyl-N4-nitrosoallophanater af steroidforbindelser. | |
DK137043B (da) | Analogifremgangsmåde til fremstilling af nitrocarbostyrilforbindelser. | |
DK139716B (da) | Analogifremgangsmåde til fremstilling af 4-aminoamfetaminderivater. | |
DK138227B (da) | Analogifremgangsmåde til fremstilling af substituerede xanthon-2-carboxylsyreforbindelser. | |
DK136909B (da) | 3-acyloxy-26,27-di-nor-cholesta-3,5-dien-25-syrealkylestere til anvendelse som mellemprodukter til fremstilling af di-nor-cholestanderivater samt fremgangsmåde til fremstilling af mellemprodukterne. | |
DK135943B (da) | Fremgangsmåde til fremstilling af propanolaminderivater. | |
DK137240C (da) | Tricycliske sulfoximider til anvendelse som mellemprodukt vedfremstilling af tilsvarende tricycliske sulfoximider,der er substitueret paa s-iminogruppen,samt fremgangsmaade til fremstilling heraf | |
DK126998B (da) | Analogifremgangsmåde til fremstilling af amino-s-triazolylbenzensulfonamidforbindelser. | |
DK139910B (da) | Analogifremgangsmåde til fremstilling af substituerede triazoler. | |
DK137924C (da) | Fremgangsmaade til fremstilling af 1,4-dihydroquinoliner | |
DK136619B (da) | Fremgangsmåde til fremstilling af dihydrokanadensolid. | |
DK139514B (da) | Analogifremgangsmåde til fremstilling af indan-1-karboxylsyrederivater. | |
DK136603B (da) | Fremgangsmåde til fremstilling af 1alfa-hydroxycholecalciferol. |